{
    "type": "ETF",
    "ucits": true,
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": true,
    "inverse": true,
    "complex_factors": [
        "Synthetic replication via total return swaps",
        "2x leveraged inverse exposure",
        "Counterparty risk from swap counterparties",
        "Daily rebalancing of leveraged inverse index",
        "Complex index construction with leverage and inverse exposure"
    ],
    "classification": "complex",
    "supporting_data": "The ETF uses synthetic replication through swap agreements to achieve its investment objective, explicitly stated as entering into financial contracts (derivatives) with swap counterparties to swap most subscription proceeds for the return on the S&P 500 2x Inverse Daily Index. The fund provides 2x leveraged inverse exposure, which is a clear leverage and inverse trigger under MiFID II complexity rules. The index is designed to provide double the opposite daily performance of the S&P 500, with daily rebalancing, which adds complexity and risk of tracking error over periods longer than one day. The fund carries significant counterparty risk as it depends on swap counterparties, and this risk is disclosed in the KIID and PRIIPs documents. The risk profile is high (category 6-7 out of 7), reflecting the leveraged and inverse nature of the product. The fund is UCITS compliant but the use of derivatives is inherent to the strategy, not just for risk management. The factsheet confirms indirect replication via swaps and highlights the leveraged inverse exposure to US equities. There are no capital protection or structured product features, but the leverage, synthetic replication, and counterparty risk clearly drive the classification as complex under MiFID II. The PRIIPs KID also indicates the product is suitable only for investors with advanced knowledge and a short-term horizon, reinforcing complexity. No references to contingent bonds or capital protection were found. Costs include a 0.70% ongoing charge but no performance fees. Overall, the combination of synthetic replication, leverage, inverse exposure, and counterparty risk leads to a 'complex' classification."
}